A Systematic Review of Myocarditis Induced by Immune Checkpoint Inhibitors: How Concerning Is the Most Common Cardiotoxicity of Immune Checkpoint Inhibitors?

Novel cancer therapies have revolutionized the management of various cancers. An immune checkpoint inhibitor (ICI) is one of these antitumor medications. ICIs, which are immune therapies, enhance the immune system's capacity to fight cancer cells. Based on the receptors that they inhibit, such...

Descripción completa

Detalles Bibliográficos
Autores principales: Moradi, Ali, Kodali, Athri, Okoye, Chiugo, Klein, Dhadon Hannah, Mohamoud, Iman, Olanisa, Olawale O, Parab, Panah, Chaudhary, Priti, Mukhtar, Sonia, Mohammed, Lubna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434730/
https://www.ncbi.nlm.nih.gov/pubmed/37602125
http://dx.doi.org/10.7759/cureus.42071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434730/
https://www.ncbi.nlm.nih.gov/pubmed/37602125
http://dx.doi.org/10.7759/cureus.42071

Ejemplares similares